iHuman (IH) Competitors $2.19 +0.06 (+2.57%) As of 03:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IH vs. VSTA, NRDY, QSG, EM, SDA, NAMI, EWCZ, HCMA, AZI, and YSXTShould you be buying iHuman stock or one of its competitors? The main competitors of iHuman include Vasta Platform (VSTA), Nerdy (NRDY), QuantaSing Group (QSG), Smart Share Global (EM), SunCar Technology Group (SDA), Jinxin Technology Holding Company American Depositary Shares (NAMI), European Wax Center (EWCZ), HCM Acquisition (HCMA), Autozi Internet Technology (Global) (AZI), and YSX Tech (YSXT). These companies are all part of the "personal services" industry. iHuman vs. Vasta Platform Nerdy QuantaSing Group Smart Share Global SunCar Technology Group Jinxin Technology Holding Company American Depositary Shares European Wax Center HCM Acquisition Autozi Internet Technology (Global) YSX Tech Vasta Platform (NASDAQ:VSTA) and iHuman (NYSE:IH) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk. Which has higher valuation and earnings, VSTA or IH? iHuman has lower revenue, but higher earnings than Vasta Platform. Vasta Platform is trading at a lower price-to-earnings ratio than iHuman, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVasta Platform$1.67B0.22-$16.78M$1.084.19iHuman$922.20M0.12$25.48M$0.268.44 Do insiders and institutionals have more ownership in VSTA or IH? 15.8% of Vasta Platform shares are owned by institutional investors. Comparatively, 4.9% of iHuman shares are owned by institutional investors. 2.0% of Vasta Platform shares are owned by insiders. Comparatively, 63.6% of iHuman shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to VSTA or IH? In the previous week, Vasta Platform had 2 more articles in the media than iHuman. MarketBeat recorded 6 mentions for Vasta Platform and 4 mentions for iHuman. iHuman's average media sentiment score of 0.73 beat Vasta Platform's score of 0.40 indicating that iHuman is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vasta Platform 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral iHuman 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate VSTA or IH? Vasta Platform presently has a consensus price target of $3.00, indicating a potential downside of 33.63%. Given Vasta Platform's stronger consensus rating and higher possible upside, equities analysts plainly believe Vasta Platform is more favorable than iHuman.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vasta Platform 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00iHuman 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, VSTA or IH? Vasta Platform has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500. Comparatively, iHuman has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Does the MarketBeat Community believe in VSTA or IH? Vasta Platform received 10 more outperform votes than iHuman when rated by MarketBeat users. However, 50.00% of users gave iHuman an outperform vote while only 44.00% of users gave Vasta Platform an outperform vote. CompanyUnderperformOutperformVasta PlatformOutperform Votes1144.00% Underperform Votes1456.00% iHumanOutperform Votes150.00% Underperform Votes150.00% Is VSTA or IH more profitable? iHuman has a net margin of 11.22% compared to Vasta Platform's net margin of -3.32%. iHuman's return on equity of 11.29% beat Vasta Platform's return on equity.Company Net Margins Return on Equity Return on Assets Vasta Platform-3.32% 1.61% 0.98% iHuman 11.22%11.29%7.45% SummaryiHuman beats Vasta Platform on 9 of the 17 factors compared between the two stocks. Get iHuman News Delivered to You Automatically Sign up to receive the latest news and ratings for IH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IH vs. The Competition Export to ExcelMetriciHumanEducational services IndustryDiscretionary SectorNYSE ExchangeMarket Cap$114.68M$967.86M$7.49B$18.97BDividend YieldN/A7.32%3.39%4.02%P/E Ratio7.8410.8216.4232.98Price / Sales0.121.537.4528.04Price / Cash3.6427.8916.4217.52Price / Book0.862.504.414.49Net Income$25.48M$22.13M$260.40M$1.02B7 Day Performance6.55%3.59%1.61%0.94%1 Month Performance-0.23%2.07%-1.91%-2.42%1 Year Performance26.97%2.83%-2.20%4.78% iHuman Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IHiHuman2.4589 of 5 stars$2.20+2.6%N/A+24.1%$114.68M$922.20M7.841,120Gap DownVSTAVasta Platform1.0786 of 5 stars$4.81-0.2%$3.00-37.6%+17.1%$385.63M$1.67B-68.701,790Upcoming EarningsShort Interest ↑News CoveragePositive NewsNRDYNerdy1.7996 of 5 stars$1.68+1.5%$2.31+38.1%-39.3%$305.60M$190.23M-4.93700Upcoming EarningsNews CoverageQSGQuantaSing GroupN/A$5.79+14.9%N/A+105.0%$296.52M$3.48B5.852,010News CoverageGap DownHigh Trading VolumeEMSmart Share GlobalN/A$1.06+1.9%N/A+51.8%$275.15M$1.84B35.355,090SDASunCar Technology Group3.6015 of 5 stars$2.60-9.1%$12.00+361.5%-65.4%$269.46M$425.99M0.00N/AShort Interest ↓Analyst RevisionNews CoverageNAMIJinxin Technology Holding Company American Depositary SharesN/A$3.10+5.4%N/AN/A$198.53M$406.40M0.00N/AGap DownEWCZEuropean Wax Center2.9202 of 5 stars$3.22-1.8%$6.94+115.5%-73.5%$178.21M$216.92M14.00110Positive NewsHCMAHCM AcquisitionN/A$10.10-1.0%N/A+26.7%$142.83MN/A0.00N/AAZIAutozi Internet Technology (Global)N/A$1.04+4.0%N/AN/A$109.18M$124.74M0.0083Positive NewsYSXTYSX TechN/A$4.76+5.3%N/AN/A$105.07M$66.14M0.0040Positive News Related Companies and Tools Related Companies Vasta Platform Alternatives Nerdy Alternatives QuantaSing Group Alternatives Smart Share Global Alternatives SunCar Technology Group Alternatives Jinxin Technology Holding Company American Depositary Shares Alternatives European Wax Center Alternatives HCM Acquisition Alternatives Autozi Internet Technology (Global) Alternatives YSX Tech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IH) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iHuman Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iHuman With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.